7,580.07

-140.32

-1.82%

51,770.31

-572.25

-1.09%

25,437.00

-747.73

-2.86%

2,811.84

-47.37

-1.66%

4.9290

-0.0600

-1.20%

19.42

+2.22

+12.91%

3,898.90

-132.50

-3.29%

77,704.05

+498.22

+0.65%

Crude Oil Dec 26

104.12

+2.12

+2.08%

US Private Equity

10,850.63

-82.20

-0.75%

Frankfurt - Delayed Quote EUR

BetterLife Pharma Inc. (NPAU.F)

0.1500 +0.0030 (+2.04%)

At close: October 30 at 8:15:12 PM GMT+1

Loading Chart for NPAU.F

Chart Range Bar

Interval:

In partnership with ChartIQ

BetterLife Pharma Appoints LifeSci Advisors as Investor Relations Firm

BetterLife Pharma Appoints LifeSci Advisors as Investor Relations Firm

BetterLife Pharma Appoints Professor Richard B. Lipton as Co-Chair of its Scientific Advisory Board

BetterLife Pharma Appoints Professor Richard B. Lipton as Co-Chair of its Scientific Advisory Board

BetterLife Pharma Appoints Sheila Leitzinger as Head of Clinical Operations

BetterLife Pharma Appoints Sheila Leitzinger as Head of Clinical Operations

BetterLife Pharma Establishes Scientific Advisory Board for Headache Program; Professor Peter Goadsby Appointed Co-Chair

BetterLife Pharma Establishes Scientific Advisory Board for Headache Program; Professor Peter Goadsby Appointed Co-Chair

BetterLife Pharma Addresses Notice of Civil Claim Filed by Steven Sangha

BetterLife Pharma Addresses Notice of Civil Claim Filed by Steven Sangha

BetterLife Pharma Announces Rescheduling and Reclassification of Annual General Meeting to Annual General and Special Meeting

BetterLife Pharma Announces Rescheduling and Reclassification of Annual General Meeting to Annual General and Special Meeting

BetterLife Pharma Inc. Announces Closing of US$100 Million Public Offering of Common Shares and Pre-Funded Warrants

BetterLife Pharma Inc. Announces Closing of US$100 Million Public Offering of Common Shares and Pre-Funded Warrants

BetterLife Pharma Inc. Announces Filing of Final Prospectus for US$100 Million Public Offering of Common Shares and Pre-Funded Warrants

BetterLife Pharma Inc. Announces Filing of Final Prospectus for US$100 Million Public Offering of Common Shares and Pre-Funded Warrants

BetterLife Pharma Appoints Charles Duncan as Director and Chair of the Audit Committee

BetterLife Pharma Appoints Charles Duncan as Director and Chair of the Audit Committee

BetterLife Pharma Inc. Announces Pricing of US$100 Million Public Offering of Common Shares and Pre-Funded Warrants

BetterLife Pharma Inc. Announces Proposed Public Offering of Common Shares and Pre-Funded Warrants

BetterLife Pharma Inc. Announces Proposed Public Offering of Common Shares and Pre-Funded Warrants

Mobilize your Website

View Site in Mobile | Classic

Share by: